Ideal candidates for semaglutide weight loss programs typically have a body mass index over 30, or a BMI of 27 with associated medical conditions like hypertension, type 2 diabetes, or elevated cholesterol
With over 100 curated dishes and tips on managing side effects, it's a good start to set you up for success
Discussion This study provides new insights into the evolving role of GLP-1 RAs in healthcare, particularly how their use amongst people with overweight or obesity coincides with first-time diagnoses of type 2 diabetes, sleep apnea, and cardiovascular disease
The supplemented group showed decreased respiratory quotient, increased fat oxidation percentage, reduced insulin levels, improved insulin sensitivity (HOMA index), reduced waist circumference, and increased resting energy expenditure compared to placebo
Realistic expectation levels and understanding of treatment limitations contribute to higher satisfaction rates